MC2185A1 - Complexes d'inclusion de n-ethoxycarbonyl-3-morpholino-sydnonimine ou de ses sels formes au moyen de derives de cyclodextrine,preparation de ces complexes et compositions pharmaceutiques contenant ces complexes - Google Patents

Complexes d'inclusion de n-ethoxycarbonyl-3-morpholino-sydnonimine ou de ses sels formes au moyen de derives de cyclodextrine,preparation de ces complexes et compositions pharmaceutiques contenant ces complexes

Info

Publication number: MC2185A1
Authority: MC; Monaco
Prior art keywords: complexes; cyclodextrin; sydnonimine; ethoxycarbonyl; morpholino
Prior art date: 1990-03-28

Application number

MC@@@@D

Other languages

English (en)

Inventor

Vikmon Maria

Szejtli Jozsef

Gaal Jozsef

Hermecz Istvan

Horvath Agnes

Munkacsi Iren

Marmarosi Katalin

Hovarth Gabor

Original Assignee

Chinoin Gyogyszer Es Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-28

Filing date

1991-03-28

Publication date

1992-09-16

1991-03-28 Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet

1992-09-16 Publication of MC2185A1 publication Critical patent/MC2185A1/fr

Links

XLFWDASMENKTKL-UHFFFAOYSA-N molsidomine Chemical compound O1C(N=C([O-])OCC)=C[N+](N2CCOCC2)=N1 XLFWDASMENKTKL-UHFFFAOYSA-N 0.000 title abstract 5
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
229920000858 Cyclodextrin Polymers 0.000 abstract 7
239000001116 FEMA 4028 Substances 0.000 abstract 3
229960004853 betadex Drugs 0.000 abstract 3
206010002383 Angina Pectoris Diseases 0.000 abstract 2
WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 2
235000011175 beta-cyclodextrine Nutrition 0.000 abstract 2
230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
230000002253 anti-ischaemic effect Effects 0.000 abstract 1
239000003416 antiarrhythmic agent Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000003527 fibrinolytic agent Substances 0.000 abstract 1
230000003480 fibrinolytic effect Effects 0.000 abstract 1
GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 abstract 1
229940080345 gamma-cyclodextrin Drugs 0.000 abstract 1
230000001077 hypotensive effect Effects 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
229960004027 molsidomine Drugs 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Veterinary Medicine (AREA)
Polymers & Plastics (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Materials Engineering (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MC@@@@D 1990-03-28 1991-03-28 Complexes d'inclusion de n-ethoxycarbonyl-3-morpholino-sydnonimine ou de ses sels formes au moyen de derives de cyclodextrine,preparation de ces complexes et compositions pharmaceutiques contenant ces complexes MC2185A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU901868A HU210921B (en)	1990-03-28	1990-03-28	Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
PCT/HU1991/000012 WO1991014680A1 (fr)	1990-03-28	1991-03-28	Complexes d'inclusion de n-ethoxycarbonyl-3-morpholino-sydnonimine ou de ses sels formes au moyen de derives de cyclodextrine, preparation de ces complexes et compositions pharmaceutiques contenant ces complexes

Publications (1)

Publication Number	Publication Date
MC2185A1 true MC2185A1 (fr)	1992-09-16

Family

ID=10956592

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MC@@@@D MC2185A1 (fr)	1990-03-28	1991-03-28	Complexes d'inclusion de n-ethoxycarbonyl-3-morpholino-sydnonimine ou de ses sels formes au moyen de derives de cyclodextrine,preparation de ces complexes et compositions pharmaceutiques contenant ces complexes

Country Status (34)

Country	Link
US (1)	US5403840A (fr)
EP (1)	EP0477315B1 (fr)
JP (1)	JP2582497B2 (fr)
KR (1)	KR950004705B1 (fr)
CN (1)	CN1051080C (fr)
AT (1)	ATE138656T1 (fr)
AU (1)	AU638824B2 (fr)
BG (1)	BG61689B1 (fr)
BR (1)	BR9105136A (fr)
CA (1)	CA2054188C (fr)
CZ (1)	CZ287353B6 (fr)
DE (1)	DE69119853T2 (fr)
DK (1)	DK0477315T3 (fr)
ES (1)	ES2090320T3 (fr)
FI (1)	FI102460B (fr)
GE (1)	GEP19991832B (fr)
GR (1)	GR3020684T3 (fr)
HR (1)	HRP920561B1 (fr)
HU (1)	HU210921B (fr)
IL (1)	IL97714A (fr)
LT (1)	LT3394B (fr)
LV (1)	LV10245B (fr)
MC (1)	MC2185A1 (fr)
MD (1)	MD679G2 (fr)
NO (1)	NO179611C (fr)
OA (1)	OA10029A (fr)
PL (1)	PL165868B1 (fr)
RO (1)	RO109649B1 (fr)
RU (1)	RU2111216C1 (fr)
SI (1)	SI9110908A (fr)
SK (1)	SK279891B6 (fr)
TJ (1)	TJ231R3 (fr)
UA (1)	UA27226C2 (fr)
WO (1)	WO1991014680A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA949182B (en) *	1993-12-02	1995-07-26	South African Druggists Ltd	Pharmaceutical composition
GB2290964A (en) *	1994-07-08	1996-01-17	Arto Olavi Urtti	Transdermal drug delivery system
US6046177A (en) *	1997-05-05	2000-04-04	Cydex, Inc.	Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
GB9915231D0 (en)	1999-06-29	1999-09-01	Pfizer Ltd	Pharmaceutical complex
FR2805462B1 (fr) *	2000-02-24	2003-08-15	Therabel Res	Nouvelle forme galenique orale a liberation prolongee de la molsidomine
ITTO20120056A1 (it) *	2012-01-24	2013-07-25	Borla Ind	Connettore per linee medicali di infusione, trasfusione e simili
ITTO20130433A1 (it) *	2013-05-29	2014-11-30	Borla Ind	Connettore per linee medicali
BE1028879B1 (fr)	2020-12-11	2022-07-12	Europharmaceuticals	Comprimé à libération prolongée de la molsidomine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1695897C3 (de) *	1966-07-04	1979-02-15	Takeda Chemical Industries Ltd	N-Acyl-sydnonimine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3221425A1 (de) *	1982-06-07	1983-12-08	Boehringer Ingelheim KG, 6507 Ingelheim	Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
DK243084A (da) *	1983-05-26	1984-11-27	Takeda Chemical Industries Ltd	Perkutane farmaceutiske praeparater til udvortes brug
DE3346614A1 (de) *	1983-12-23	1985-07-04	Anton Hummel Gmbh Metallwarenfabrik, 7808 Waldkirch	Entlueftungsventil insbesondere zum entlueften von heizsystemen
GB8506792D0 (en) *	1985-03-15	1985-04-17	Janssen Pharmaceutica Nv	Derivatives of y-cyclodextrin
DE3522191A1 (de) *	1985-06-21	1987-01-15	Cassella Ag	Photostabilisierung von sydnoniminen
GB8613688D0 (en) *	1986-06-05	1986-07-09	Euro Celtique Sa	Pharmaceutical composition
JPH0819004B2 (ja) *	1986-12-26	1996-02-28	日清製粉株式会社	徐放性医薬製剤
IT1204725B (it) *	1987-06-17	1989-03-10	Edmond Pharma Srl	Complessi di inclusione del dipiridamolo con ciclodestrine
EP0326196B1 (fr) *	1988-01-14	1992-03-25	Akzo N.V.	Composition pharmaceutique aqueuse
US5120732A (en) *	1988-06-14	1992-06-09	Cassella Aktiengesellschaft	Substituted 3-aminosyndone imines, a process for their preparation and their use
IT1227626B (it) *	1988-11-28	1991-04-23	Vectorpharma Int	Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
SE8904296D0 (sv) *	1989-12-21	1989-12-21	Pharmacia Ab	Transdermal system
HU211648A9 (en) *	1990-03-28	1995-12-28	Chinoin Gyogyszer Es Vegyeszet	Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

1990
- 1990-03-28 HU HU901868A patent/HU210921B/hu unknown
1991
- 1991-03-28 RO RO148827A patent/RO109649B1/ro unknown
- 1991-03-28 DE DE69119853T patent/DE69119853T2/de not_active Expired - Lifetime
- 1991-03-28 WO PCT/HU1991/000012 patent/WO1991014680A1/fr not_active Ceased
- 1991-03-28 SI SI9110908A patent/SI9110908A/sl unknown
- 1991-03-28 CA CA002054188A patent/CA2054188C/fr not_active Expired - Lifetime
- 1991-03-28 IL IL9771491A patent/IL97714A/en not_active IP Right Cessation
- 1991-03-28 CN CN91102687A patent/CN1051080C/zh not_active Expired - Fee Related
- 1991-03-28 BR BR919105136A patent/BR9105136A/pt not_active Application Discontinuation
- 1991-03-28 US US07/807,852 patent/US5403840A/en not_active Expired - Lifetime
- 1991-03-28 ES ES91906726T patent/ES2090320T3/es not_active Expired - Lifetime
- 1991-03-28 DK DK91906726.4T patent/DK0477315T3/da active
- 1991-03-28 UA UA5010581A patent/UA27226C2/uk unknown
- 1991-03-28 AU AU75745/91A patent/AU638824B2/en not_active Expired
- 1991-03-28 SK SK851-91A patent/SK279891B6/sk unknown
- 1991-03-28 MC MC@@@@D patent/MC2185A1/fr unknown
- 1991-03-28 AT AT91906726T patent/ATE138656T1/de not_active IP Right Cessation
- 1991-03-28 JP JP3507012A patent/JP2582497B2/ja not_active Expired - Lifetime
- 1991-03-28 CZ CS1991851A patent/CZ287353B6/cs not_active IP Right Cessation
- 1991-03-28 PL PL91293022A patent/PL165868B1/pl unknown
- 1991-03-28 RU SU5010581A patent/RU2111216C1/ru active
- 1991-03-28 EP EP91906726A patent/EP0477315B1/fr not_active Expired - Lifetime
- 1991-03-28 KR KR1019910701670A patent/KR950004705B1/ko not_active Expired - Fee Related
- 1991-11-08 OA OA60094A patent/OA10029A/en unknown
- 1991-11-26 FI FI915569A patent/FI102460B/fi active
- 1991-11-27 NO NO914649A patent/NO179611C/no not_active IP Right Cessation
- 1991-11-27 BG BG95531A patent/BG61689B1/bg unknown
1992
- 1992-09-28 HR HRP-908/91A patent/HRP920561B1/xx not_active IP Right Cessation
- 1992-12-30 LV LVP-92-590A patent/LV10245B/en unknown
1993
- 1993-03-05 LT LTIP386A patent/LT3394B/lt not_active IP Right Cessation
- 1993-06-16 GE GEAP1993884A patent/GEP19991832B/en unknown
1994
- 1994-08-25 MD MD94-0333A patent/MD679G2/ro not_active IP Right Cessation
- 1994-11-28 TJ TJ94000007A patent/TJ231R3/xx unknown
1996
- 1996-07-31 GR GR960402042T patent/GR3020684T3/el unknown

Also Published As

Publication number	Publication date
US5403840A (en)	1995-04-04
DE69119853T2 (de)	1996-10-10
DE69119853D1 (de)	1996-07-04
LT3394B (en)	1995-09-25
NO914649L (no)	1991-11-27
AU7574591A (en)	1991-10-21
SI9110908A (sl)	1998-06-30
LV10245B (en)	1995-08-20
WO1991014680A1 (fr)	1991-10-03
OA10029A (en)	1996-10-14
MD679F1 (en)	1997-02-28
CA2054188C (fr)	1996-07-23
CN1056688A (zh)	1991-12-04
FI102460B1 (fi)	1998-12-15
JPH04506362A (ja)	1992-11-05
MD679G2 (ro)	1997-11-30
BG61689B1 (bg)	1998-03-31
EP0477315A1 (fr)	1992-04-01
JP2582497B2 (ja)	1997-02-19
HUT58109A (en)	1992-01-28
KR950004705B1 (ko)	1995-05-04
EP0477315B1 (fr)	1996-05-29
PL293022A1 (en)	1992-12-28
HU901868D0 (en)	1990-08-28
IL97714A0 (en)	1992-06-21
PL165868B1 (pl)	1995-02-28
HU210921B (en)	1995-09-28
NO179611B (no)	1996-08-05
ATE138656T1 (de)	1996-06-15
NO179611C (no)	1996-11-13
LV10245A (lv)	1994-10-20
GR3020684T3 (en)	1996-10-31
LTIP386A (en)	1994-12-27
AU638824B2 (en)	1993-07-08
SK279891B6 (sk)	1999-05-07
GEP19991832B (en)	1999-11-05
DK0477315T3 (da)	1996-09-30
FI915569A0 (fi)	1991-11-26
FI102460B (fi)	1998-12-15
ES2090320T3 (es)	1996-10-16
BG95531A (bg)	1993-12-24
CS85191A3 (en)	1991-11-12
RU2111216C1 (ru)	1998-05-20
CA2054188A1 (fr)	1991-09-29
CZ287353B6 (cs)	2000-11-15
UA27226C2 (uk)	2000-08-15
NO914649D0 (no)	1991-11-27
TJ231R3 (en)	1999-11-24
CN1051080C (zh)	2000-04-05
HRP920561A2 (hr)	1994-04-30
RO109649B1 (ro)	1995-04-28
HRP920561B1 (en)	1999-12-31
BR9105136A (pt)	1992-08-04
KR920701182A (ko)	1992-08-11
IL97714A (en)	1995-03-30

Publication	Publication Date	Title
US6284746B1 (en)	2001-09-04	Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
RU94028890A (ru)	1995-11-10	Композиции производных циклодекстрина, композиции, содержащие лекарство и производные циклодекстринов
MC2185A1 (fr)	1992-09-16	Complexes d'inclusion de n-ethoxycarbonyl-3-morpholino-sydnonimine ou de ses sels formes au moyen de derives de cyclodextrine,preparation de ces complexes et compositions pharmaceutiques contenant ces complexes
KR960700074A (ko)	1996-01-19	고용해성다성분봉입체착화합물(Highy soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin)
EA199800910A1 (ru)	1999-04-29	Композиции, комплексы включения фармацевтически приемлемой соли зипразидона и циклодекстрина и соли зипразидона
CA2074186A1 (fr)	1991-07-24	Derives de cyclodextrines plus solubles dans l'eau et leur utilisation
EP0803243A3 (fr)	1997-11-12	Produits dentaires contenant des cyclodextrines et des composés phénoliques
AU3854095A (en)	1996-06-06	Novel complexes and their compositions
BR9805875A (pt)	2000-05-02	Composições farmacêuticas de droloxifeno.
AU5535900A (en)	2001-01-22	Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
DE59909196D1 (de)	2004-05-19	Kombination aus norpregnan derivaten und cyclodextrin
KR960705587A (ko)	1996-11-08	개선된 약제학적 성질을 가진 에스트라무스틴 제제(Estramustine formulations with improved pharmaceutical properties)
Másson et al.	1999	Synthesis of cyclic glycerol ether cyclodextrin derivatives and investigation of their binding properties with drugs
刘勇 et al.	1995	Water-soluble crosslinked β-cyclodextrin polymer inclusion complexes with C60
ES2094080B1 (es)	1997-08-01	Procedimiento de preparacion de complejos de inclusion de tenoxicam con ciclodextrinas.